mortality/aging
|
• no live mutants are observed at P0-P14, although at least some survive gestation
|
respiratory system
|
• severe defects in lung airway development are observed at E14.5, E16.5 and E18.5
• >40% reduction in cell proliferation in both the lung epithelia and mesenchyme is observed, without any significant changes in apoptosis
• however, proximal-distal epithelial patterning of the lung airways is normal at E18.5
|
|
• >40% reduction of cell proliferation in lung mesenchyme, without any significant changes in apoptosis
|
|
• branching morphogenesis is reduced as shown by the dilated nature of developing airways
|
|
• overall lung size is reduced at both E14.5 and E18.5
|
|
• lung-to-body weight ratios are significantly reduced at both E17.5 and P0
|
|
• distal airspace luminal area is significantly increased at both E14.5 (~3-fold) and E18.5 (~2-fold)
|
digestive/alimentary system
|
• both smooth and skeletal muscle differentiation is disrupted in mutant esophagi
• at E14.5, the smooth muscle surrounding the mutant esophagus is thinner than normal
• by E18.5, mutants display severely dilated esophagi with a very thin muscular layer
• however, no differences in apoptosis or cell proliferation are observed in mutant esophagi at E14.5
|
|
• at E14.5, the smooth muscle surrounding the mutant esophagus is thinner than normal
|
|
• by E18.5, mutants display severely dilated esophagi
|
muscle
|
• at E14.5, the smooth muscle surrounding the mutant esophagus is thinner than normal
|
cellular
|
• >40% reduction of cell proliferation in lung mesenchyme, without any significant changes in apoptosis
|